FGD5-AS1: A Potential Drug Target and Biomarker (G100505641)

Target Name: FGD5-AS1

NCBI ID: G100505641

FGD5-AS1

Other Name(s): FGD5 antisense RNA 1 | FGD5-AS1 variant 1

FGD5-AS1: A Potential Drug Target and Biomarker

FGD5-AS1, also known as FGD5-AS1 gene, is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The gene is located on chromosome 16 and encodes for a protein known as FGD5-AS1. FGD5-AS1 is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling.

The discovery of FGD5-AS1 as a potential drug target and biomarker began with the identification of its potential interactors in the GPCR family. Several studies have shown that FGD5-AS1 interacts with several different proteins, including the transcription factor, NF-kappa-B, and the protein, PDGF-BB. These interactions suggest that FGD5-AS1 may play a role in cellular signaling and may be a potential drug target.

FGD5-AS1 has also been shown to interact with several other proteins, including the protein, TGR5. TGR5 is a non-coding RNA molecule that has been shown to play a role in stem cell self-renewal and has been linked to a variety of diseases, including cancer. The interaction between FGD5-AS1 and TGR5 suggests that FGD5-AS1 may be a potential biomarker for cancer and may be a target for new therapies.

FGD5-AS1 has also been shown to interact with the protein, FAK. FAK is a protein that has been linked to a variety of diseases, including cancer and neurodegenerative diseases. The interaction between FGD5-AS1 and FAK suggests that FGD5-AS1 may be a potential drug target for these diseases.

In addition to its potential interactions with other proteins, FGD5-AS1 has also been shown to play a role in cellular signaling. The FGD5-AS1 gene has been shown to encode for a protein that is involved in the intracellular signaling pathway known as the TGF-β pathway. This suggests that FGD5-AS1 may be involved in the regulation of cellular processes that are important for the development and progression of diseases.

The potential drug target and biomarker properties of FGD5-AS1 make it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of FGD5-AS1 in cellular signaling and to determine its potential as a drug target and biomarker.

Protein Name: FGD5 Antisense RNA 1

The "FGD5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGD5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets